Filed 2.6y ago· Nov 2, 2023
29 days to disclose
Thomas R Carper
DSenateDelaware
↑bought
Revance Therapeutics, Inc. -
RVNC
$1K-$15K
Trade dateOct 4, 2023
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–14 of 14
Filed 2.6y ago· Nov 2, 2023
29 days to discloseThomas R Carper
DSenateDelaware
↓sold
Structure Therapeutics
GPCR
$1K-$15K
Trade dateOct 4, 2023
Filed 2.7y ago· Sep 5, 2023
11 days to discloseThomas R Carper
DSenateDelaware
↓sold
Intellia Therapeutics
NTLA
$1K-$15K
+126.6% vs S&P 500
Trade dateAug 25, 2023
Intellia Therapeutics, Inc. -
Filed 2.9y ago· Jun 30, 2023
39 days to discloseThomas R Carper
DSenateDelaware
↑bought
Intellia Therapeutics
NTLA
$1K-$15K
−139.8% vs S&P 500
Trade dateMay 22, 2023
Intellia Therapeutics, Inc. -
Filed 3.1y ago· May 1, 2023
5 days to discloseThomas R Carper
DSenateDelaware
↑bought
Novartis Ag
NVS
$1K-$15K
−34.7% vs S&P 500
Trade dateApr 26, 2023
Filed 4.3y ago· Feb 3, 2022
16 days to discloseThomas R Carper
DSenateDelaware
↓sold
AbbVie
ABBV
$1K-$15K
+11.1% vs S&P 500
Trade dateJan 18, 2022
Filed 4.3y ago· Feb 3, 2022
16 days to discloseThomas R Carper
DSenateDelaware
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−65.9% vs S&P 500
Trade dateJan 18, 2022
Filed 4.3y ago· Feb 3, 2022
16 days to discloseThomas R Carper
DSenateDelaware
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−20.3% vs S&P 500
Trade dateJan 18, 2022
Filed 4.5y ago· Dec 4, 2021
5 days to discloseThomas R Carper
DSenateDelaware
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−46.2% vs S&P 500
Trade dateNov 29, 2021
Filed 5.1y ago· May 17, 2021
178 days to disclose · 133 past 45-day windowThomas R Carper
DSenateDelaware
↑bought
AbbVie
ABBV
$1K-$15K
Trade dateNov 20, 2020
Filed 5.1y ago· May 17, 2021
178 days to disclose · 133 past 45-day windowThomas R Carper
DSenateDelaware
↑bought
Intellia Therapeutics
NTLA
$1K-$15K
Trade dateNov 20, 2020
Filed 5.1y ago· May 17, 2021
312 days to disclose · 267 past 45-day windowThomas R Carper
DSenateDelaware
↓sold
AbbVie
ABBV
$1K-$15K
Trade dateJul 9, 2020
Filed 5.1y ago· May 17, 2021
312 days to disclose · 267 past 45-day windowThomas R Carper
DSenateDelaware
↑bought
Pfizer
PFE
$1K-$15K
Trade dateJul 9, 2020
Filed 5.1y ago· May 17, 2021
410 days to disclose · 365 past 45-day windowThomas R Carper
DSenateDelaware
↑bought
Novo Nordisk
NVO
$1K-$15K
Trade dateApr 2, 2020
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Nov 2, 2023 2.6y ago | Thomas R Carper DSenateDelaware | ↑bought | Revance Therapeutics, Inc. - RVNC | Oct 4, 2023 29 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 2, 2023 2.6y ago | Thomas R Carper DSenateDelaware | ↓sold | Structure Therapeutics GPCR | Oct 4, 2023 29 days to disclose | price pending | $1K-$15K midpoint $8K |
Sep 5, 2023 2.7y ago | Thomas R Carper DSenateDelaware | ↓sold | Intellia Therapeutics NTLA Intellia Therapeutics, Inc. - | Aug 25, 2023 11 days to disclose | Smart sell·+$5.1K+64.4% +126.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 30, 2023 2.9y ago | Thomas R Carper DSenateDelaware | ↑bought | Intellia Therapeutics NTLA Intellia Therapeutics, Inc. - | May 22, 2023 39 days to disclose | Bad buy·−$5.5K-69.3% −139.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 1, 2023 3.1y ago | Thomas R Carper DSenateDelaware | ↑bought | Novartis Ag NVS | Apr 26, 2023 5 days to disclose | Good buy·+$3.3K+41.9% −34.7% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 3, 2022 4.3y ago | Thomas R Carper DSenateDelaware | ↓sold | AbbVie ABBV | Jan 18, 2022 16 days to disclose | Missed gain·−$3.6K-45.3% +11.1% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 3, 2022 4.3y ago | Thomas R Carper DSenateDelaware | ↑bought | Bristol-Myers Squibb BMY | Jan 18, 2022 16 days to disclose | Bad buy·−$762-9.5% −65.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 3, 2022 4.3y ago | Thomas R Carper DSenateDelaware | ↑bought | Johnson & Johnson JNJ | Jan 18, 2022 16 days to disclose | Good buy·+$2.9K+36.1% −20.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 4, 2021 4.5y ago | Thomas R Carper DSenateDelaware | ↑bought | Bristol-Myers Squibb BMY | Nov 29, 2021 5 days to disclose | Good buy·+$596+7.4% −46.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 17, 2021 5.1y ago | Thomas R Carper DSenateDelaware | ↑bought | AbbVie ABBV | Nov 20, 2020 178 days to disclose · 133 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 17, 2021 5.1y ago | Thomas R Carper DSenateDelaware | ↑bought | Intellia Therapeutics NTLA | Nov 20, 2020 178 days to disclose · 133 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 17, 2021 5.1y ago | Thomas R Carper DSenateDelaware | ↓sold | AbbVie ABBV | Jul 9, 2020 312 days to disclose · 267 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 17, 2021 5.1y ago | Thomas R Carper DSenateDelaware | ↑bought | Pfizer PFE | Jul 9, 2020 312 days to disclose · 267 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 17, 2021 5.1y ago | Thomas R Carper DSenateDelaware | ↑bought | Novo Nordisk NVO | Apr 2, 2020 410 days to disclose · 365 past 45-day window | price pending | $1K-$15K midpoint $8K |